Sarepta Therapeutics
SRPT
SRPT
148 hedge funds and large institutions have $661M invested in Sarepta Therapeutics in 2016 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
38% less call options, than puts
Call options by funds: $270M | Put options by funds: $436M
Holders
148
Holding in Top 10
3
Calls
$270M
Puts
$436M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$11.9M | |
| 3 | +$9.96M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$9.69M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$9.39M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$21.2M | |
| 3 | -$15.7M | |
| 4 |
D.E. Shaw & Co
New York
|
-$14.7M |
| 5 |
PC
PointState Capital
New York
|
-$14.3M |